TP53 and neoplasm: Differential gene expression analysis was performed by comparing tumours carrying these variants to TP53 wild-type tumours, identifying pathways enriched among significantly up- or downregulated genes (LFC ≥ 0.5 or ≤−0.5, padj < 0.05).